Quantcast

Latest Sunitinib Stories

2006-06-04 13:28:37

By Toni Clarke ATLANTA (Reuters) - A kidney cancer drug made by Bayer AG and Onyx Pharmaceuticals Inc. showed promise in a small lung cancer trial, according to data released on Sunday, further fueling competition with a drug from Pfizer Inc.

2006-06-04 11:31:45

By Toni Clarke ATLANTA (Reuters) - For the first time in decades there are new treatments available for kidney cancer, and as more data emerges about their efficacy, the competition looks set to heat up.

2006-06-04 06:06:43

By Toni Clarke ATLANTA (Reuters) - Wyeth said on Sunday that interim results of a late-stage trial of its experimental kidney cancer drug significantly increased survival in patients compared to standard therapy.

2006-06-04 06:01:57

By Ransdell Pierson NEW YORK (Reuters) - Pfizer Inc.'s kidney cancer drug Sutent will soon become the favored first-line treatment for advanced forms of the disease, based on its ability to prolong survival in a late-stage trial described on Sunday, researchers said.

2006-06-03 15:11:46

By Toni Clarke ATLANTA (Reuters) - Using combinations of "smart bomb" cancer drugs that target specific proteins and avoid the indiscriminate cell destruction of chemotherapy may be the wave of the future for cancer patients, experts say.

2006-06-03 13:00:00

A Pfizer Inc. kidney cancer drug has also shown promise in a small mid-stage trial as a treatment for the most common form of lung cancer, researchers said on Saturday.

2005-12-21 09:44:55

By Susan Heavey WASHINGTON (Reuters) - The U.S. Food and Drug Administration approved a new drug to treat the most common type of kidney cancer on Tuesday, hailing it as a major advance in slowing tumor growth.

2005-12-20 18:46:48

By Susan Heavey WASHINGTON (Reuters) - The U.S. Food and Drug Administration approved a new drug to treat the most common type of kidney cancer on Tuesday, hailing it as a major advance in slowing tumor growth.

2005-11-03 14:47:04

Updated results from a Phase III trial presented at the 13th European Cancer Conference (ECCO) show that sunitinib (SU11248) prolongs both progression-free and overall survival in patients with progressive metastatic and/or unresectable GIST whose disease has failed to respond to the standard therapy - imatinib mesylate.

2005-09-08 08:06:36

By Ben Hirschler, European Pharmaceuticals Correspondent LONDON, Sept 8 - Pfizer Inc is ready to launch a patient-monitoring scheme to assess the safety of its novel inhaled-insulin drug Exubera if the product is approved for use, its worldwide head of development said on Thursday.


Word of the Day
dwale
  • The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
  • A sleeping-potion; a soporific.
  • To mutter deliriously.
The word 'dwale' comes from an Old English word meaning 'error, doubt, delusion.'
Related